From: An examination of user costs in relation to smokers using a cessation service based in the UK
Variable | Levels | 12 weeks | |||||
---|---|---|---|---|---|---|---|
N | Total cost (£) | Cost per head (£) | N quits | Quit rate (%) | Mean CPQ (95% CI) (£) | ||
Age | 12–19 | 509 | 49,133 | 96.53 | 116 | 22.79 | 423.56 (369.45, 492.60) |
20–29 | 1189 | 127,504 | 107.24 | 296 | 24.89 | 430.76 (395.95, 470.56) | |
30–49 | 3911 | 512,284 | 130.99 | 1262 | 32.27 | 405.93 (391.53, 423.23) | |
50–69 | 2955 | 419,963 | 142.12 | 1068 | 36.14 | 393.22 (378.45, 409.60) | |
70+ | 538 | 75,050 | 139.50 | 192 | 35.69 | 390.88 (357.16, 427.00) | |
Gender | Male | 4249 | 561,404 | 132.13 | 1425 | 33.54 | 393.97 (380.36, 407.97) |
Female | 4867 | 623,127 | 128.03 | 1510 | 31.03 | 412.67 (398.41, 427.01) | |
Treatment | NRT | 7373 | 850,191 | 115.31 | 2117 | 28.71 | 401.60 (389.91, 414.63) |
varenicline | 1708 | 330,035 | 193.23 | 799 | 46.78 | 413.06 (395.16, 433.55) | |
bupropion | 35 | 4305 | 122.99 | 19 | 54.29 | 226.56 (177.12, 314.21) | |
FTND | 0–3 | 1534 | 236,567 | 153.62 | 622 | 40.55 | 378.87 (359.35, 399.99) |
4–5 | 1884 | 299,362 | 158.90 | 727 | 38.59 | 411.78 (393.08, 433.31) | |
6–7 | 1676 | 270,188 | 161.21 | 641 | 38.25 | 421.51 (401.06, 444.88) | |
8–10 | 766 | 120,191 | 156.91 | 236 | 30.81 | 509.28 (464.80, 562.87) | |
Deprivation | 1–3 | 886 | 136,039 | 153.54 | 319 | 36.00 | 426.45 (396.92, 460.57) |
4–6 | 1838 | 266,099 | 144.78 | 635 | 34.55 | 419.05 (398.11, 443.28) | |
7–8 | 2157 | 300,324 | 139.23 | 698 | 32.36 | 430.26 (408.13, 451.16) | |
9–10 | 3321 | 451,353 | 135.91 | 1180 | 35.53 | 382.50 (369.26, 397.69) |